- Home
- SLNO vs ESBA Comparison
SLNO vs ESBA Comparison
Compare SLNO & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- ESBA
- Stock Information
- Founded
- SLNO 1999
- ESBA N/A
- Country
- SLNO United States
- ESBA United States
- Employees
- SLNO N/A
- ESBA N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ESBA
- Sector
- SLNO Health Care
- ESBA
- Exchange
- SLNO Nasdaq
- ESBA NYSE
- Market Cap
- SLNO 2.3B
- ESBA 2.2B
- IPO Year
- SLNO 2014
- ESBA 2013
- Fundamental
- Price
- SLNO $71.45
- ESBA $7.76
- Analyst Decision
- SLNO Strong Buy
- ESBA
- Analyst Count
- SLNO 8
- ESBA 0
- Target Price
- SLNO $95.75
- ESBA N/A
- AVG Volume (30 Days)
- SLNO 1.8M
- ESBA 8.3K
- Earning Date
- SLNO 05-08-2025
- ESBA 01-01-0001
- Dividend Yield
- SLNO N/A
- ESBA 1.81%
- EPS Growth
- SLNO N/A
- ESBA N/A
- EPS
- SLNO N/A
- ESBA 0.28
- Revenue
- SLNO N/A
- ESBA $763,152,000.00
- Revenue This Year
- SLNO N/A
- ESBA N/A
- Revenue Next Year
- SLNO N/A
- ESBA N/A
- P/E Ratio
- SLNO N/A
- ESBA $27.36
- Revenue Growth
- SLNO N/A
- ESBA 3.19
- 52 Week Low
- SLNO $36.61
- ESBA $7.41
- 52 Week High
- SLNO $73.97
- ESBA $11.50
- Technical
- Relative Strength Index (RSI)
- SLNO 82.97
- ESBA 33.87
- Support Level
- SLNO $48.29
- ESBA $7.57
- Resistance Level
- SLNO $73.97
- ESBA $8.10
- Average True Range (ATR)
- SLNO 3.17
- ESBA 0.13
- MACD
- SLNO 2.71
- ESBA 0.01
- Stochastic Oscillator
- SLNO 91.28
- ESBA 30.00
Stock Price Comparison Chart: SLNO vs ESBA
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.